Canada· CA-DIN-02375176
NEXHA
A medicinal product containing hyaluronate sodium, registered in Canada by VETOQUINOL N A INC.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- HYALURONATE SODIUM
- Manufacturer
- VETOQUINOL N A INC
- Country
- Canada (CA)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hyaluronate sodium in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAactive HA 0.1% eye dropsTriOn Pharma Ltd
- FinlandArtzalOrifarm Oy
- PolandHyalganDelfarma Sp. z o.o.
- SwitzerlandIalugen, cremaIBSA Institut Biochimique SA
- United StatesSHINE pH CLEANSINGCH BIO CO., LTD.
- GermanyHyalanPharma Stulln Gmbh
- CzechiaHYALGANFidia Farmaceutici S.p.A., Abano Terme (PD)
- SwedenHyalgan 10 mg/ml Injektionsvätska, lösningEbb Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Hyalgan
- Belgium · Hyalgan
- Bulgaria · Хиалган, Хилора
- Cyprus · Arthryal, Hyalgan
- Czechia · Hyalgan
- Germany · Hyalan, Hyalart
- Spain · Hyalgan
- France · Hyalgan
- Greece · Arthryal, Gonilert
- Hungary · Conheal, Hyalgan
- Italy · Collirio Alfa Occhio Secco, Connettivina
- Luxembourg · Hyalgan
- Poland · Hyalgan
- Portugal · Hyalart
- Romania · Hyalgan
- Slovakia · Hyalgan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2dbc74e-0fbc-4afb-925b-5c9827f9f9c3 GET /v1/drugs/e2dbc74e-0fbc-4afb-925b-5c9827f9f9c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02375176",
"form": "SOLUTION",
"class": "Veterinary",
"routes": [
"INTRA-ARTICULAR",
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": null,
"schedule": [
"Prescription"
],
"drug_code": "86056",
"strengths": [
"10 MG"
],
"ahfs_class": null,
"substances": [
"HYALURONATE SODIUM"
],
"product_categorization": null
}See everything about hyaluronate sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.